Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Women's Cancer Center of Nevada (WCCN) is a premier medical group and clinical research institution specializing in gynecologic oncology and women's health. Founded in 1998 by Dr. Nicola Spirtos, the center is the largest group of gynecologic oncologists in Nevada and serves as a full-member institution of the Gynecologic Oncology Group (GOG). WCCN operates a robust research department that conducts numerous Phase I-III clinical trials for advanced therapies, including PARP inhibitors, antibody-drug conjugates, and immunotherapies. The center provides comprehensive care ranging from advanced robotic surgery and chemotherapy to genetic counseling and survivorship programs. In 2025, the organization debuted a new state-of-the-art headquarters in the Las Vegas Medical District to expand its clinical and research capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Women's Cancer Center.